AKEBIA THERAPEUTICS, INC. — Operating Income by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/579cbd29-15a8-441e-a592-2e898428e2ad/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $23.5M | 2025-01-01 – 2025-12-31 | evidence 0001517022-26-000020 |
| FY 2024 | $-50.5M | 2024-01-01 – 2024-12-31 | evidence 0001628280-25-012470 |
| FY 2023 | $-46.3M | 2023-01-01 – 2023-12-31 | evidence 0001628280-24-011270 |
| FY 2022 | $-80.8M | 2022-01-01 – 2022-12-31 | evidence 0001628280-23-030697 |
| FY 2021 | $-264.5M | 2021-01-01 – 2021-12-31 | evidence 0001628280-23-030697 |
| FY 2020 | $-377.8M | 2020-01-01 – 2020-12-31 | evidence 0001628280-23-030697 |
| FY 2019 | $-286.3M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-010491 |
| FY 2018 | $-178.2M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-009340 |
| FY 2017 | $-76.7M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-009340 |
| FY 2016 | $-136.5M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-003466 |
| FY 2015 | $-61.5M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-014700 |
| FY 2014 | $-37.9M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-001260 |
| FY 2013 | $-76.9M | 2007-02-27 – 2014-03-31 | evidence 0001193125-14-193535 |
| FY 2012 | $-8.5M | 2012-01-01 – 2012-12-31 | evidence 0001564590-15-001260 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
AKEBIA THERAPEUTICS, INC. — all facts · Revenue · Net Income